Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05744_nanopub.RAwy5YGsFSz6F8sSw6PguRDfJnhrh-dtuK5NC2Cg48pFM#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05744 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05744 label "CRx-139 [drugbank:DB05744]" assertion.
- drugbank:DB05744 seeAlso DB05744 assertion.
- drugbank:DB05744 description "CRx-139 is an oral synergistic combination drug candidates with novel mechanisms of action targeting multiple biological pathways simultaneously. It is a dissociated steroid designed to enhance the immuno-modulatory activity of a low-dose glucocorticoid steroid without a comparable increase in steroid-related side effects. The synergistic combination containing low doses of the glucocorticoid steroid prednisolone and the antidepressant paroxetine. This novel synergistic combination is developed for the treatment of immuno-inflammatory diseases." assertion.
- drugbank:DB05744 identifier "drugbank:DB05744" assertion.
- drugbank:DB05744 title "CRx-139" assertion.
- drugbank:DB05744 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05744 drugbank_vocabulary:drugbank-id "DB05744" assertion.
- drugbank:DB05744 bio2rdf_vocabulary:x-identifiers.org DB05744 assertion.
- drugbank:DB05744 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05744" assertion.
- drugbank:DB05744 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05744 bio2rdf_vocabulary:identifier "DB05744" assertion.